China Health Reforms Both Attract, Worry Most Drug MNCs
This article was originally published in PharmAsia News
Executive Summary
China's healthcare reform efforts are seen as a Mecca for sales expansion by multinational drug companies but Pfizer Inc. and Merck & Co. may be seeing a downside to the move